Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
295
-
Total 13F shares, excl. options
-
89M
-
Shares change
-
+4.87M
-
Total reported value, excl. options
-
$7.51B
-
Value change
-
+$405M
-
Put/Call ratio
-
0.64
-
Number of buys
-
150
-
Number of sells
-
-148
-
Price
-
$84.43
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2019
378 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q2 2019.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89M shares
of 99.6M outstanding shares and own 89.31% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (9.35M shares), FMR LLC (9.21M shares), VANGUARD GROUP INC (8.12M shares), BlackRock Inc. (5.66M shares), Capital International Investors (5.63M shares), PERCEPTIVE ADVISORS LLC (4.02M shares), Bellevue Group AG (3.55M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.38M shares), HealthCor Management, L.P. (2.37M shares), and STATE STREET CORP (1.86M shares).
This table shows the top 295 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.